{"product_id":"thrombosis-thromboembolism-2022","title":"Thrombosis \u0026 Thromboembolism 2022","description":"\u003ch3\u003eThrombosis \u0026amp; Thromboembolism 2022\u003c\/h3\u003e\n\u003cstrong\u003eNo. of files= 45 Videos + 2 PDFs\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eFile Size = 12.30 GB\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThrombosis \u0026amp; Thromboembolism 2022 This online course from the North American Thrombosis Forum provides a comprehensive review of the most significant changes and advances impacting the care of patients who have — or are at risk for — thrombotic disorders. World-renowned experts and leading clinical faculty share key updates on the prevention, diagnosis, and treatment of thrombosis and related conditions.\u003cbr\u003e\u003ch4\u003eThrombosis and Thromboembolism is continuing medical education that will help you to:\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eIdentify the etiology and pathophysiology of atherothrombosis\u003c\/li\u003e\n\u003cli\u003eRecognize the link between inflammation and thrombotic illnesses\u003c\/li\u003e\n\u003cli\u003eExplain new tools for stroke prevention and prediction in atrial fibrillation\u003c\/li\u003e\n\u003cli\u003eIdentify the optimal duration of anticoagulation for PE and DVT\u003c\/li\u003e\n\u003cli\u003eProvide advanced therapies such as thrombolysis, catheter-directed therapy, and surgical embolectomy\u003c\/li\u003e\n\u003cli\u003eExplain the connection between diabetes, metabolic syndrome, and major adverse cardiac events\u003c\/li\u003e\n\u003cli\u003eProvide patients with useful insights into how a heart-healthy diet can help prevent thrombosis\u003c\/li\u003e\n\u003cli\u003eManage a high-risk pregnancy\u003c\/li\u003e\n\u003cli\u003eAnd more…\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eLearning Objectives\u003c\/h4\u003e\u003cbr\u003eAt the conclusion of this activity, you will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIdentify the etiology and pathophysiology of atherothrombosis\u003c\/li\u003e\n\u003cli\u003eRecognize the link between inflammation and thrombotic illnesses\u003c\/li\u003e\n\u003cli\u003eExplain new tools for stroke prevention (and stroke prediction) in atrial fibrillation\u003c\/li\u003e\n\u003cli\u003eIdentify the optimal duration of anticoagulation for PE and DVT\u003c\/li\u003e\n\u003cli\u003eProvide advanced therapy beyond anticoagulation in PE and DVT: thrombolysis, catheter-directed therapy, surgical embolectomy\u003c\/li\u003e\n\u003cli\u003eExplain the connection between diabetes, metabolic syndrome, and major adverse cardiac events\u003c\/li\u003e\n\u003cli\u003eProvide patients with useful insights into how a heart-healthy diet can help prevent thrombosis\u003c\/li\u003e\n\u003cli\u003eManage a high-risk pregnancy\u003c\/li\u003e\n\u003cli\u003eIntended Audience\u003c\/li\u003e\n\u003cli\u003eThis educational activity was designed for physicians, nurse practitioners (NPs), and physician assistants (PAs) interested in changes and advances impacting the care of patients who have or are at risk for thrombotic disorders.\u003c\/li\u003e\n\u003cli\u003eTOPICS \/ SPEAKERS\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNovel Targets For Atherosclerosis Prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eWhat’s New with TG and AngPTL3 – Aruna D. Pradhan, MD, MPH, MSc\u003c\/li\u003e\n\u003cli\u003eWhat’s New with Lp(a) – Samia Mora, MD\u003c\/li\u003e\n\u003cli\u003eWhat’s New with LDL and ApoB – Jorge Plutzky, MD\u003c\/li\u003e\n\u003cli\u003eWhat’s New with Inflammatory Targets – Paul M. Ridker, MD, MPH\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – John F. Keaney, Jr., MD – Moderator\u003c\/li\u003e\n\u003cli\u003ePeripheral Arterial Disease\u003c\/li\u003e\n\u003cli\u003ePAD – Pathways for Optimizing Cardiovascular and Limb Outcomes – Marc P. Bonaca, MD, MPH\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – Marie D. Gerhard-Herman, MD – Moderator\u003c\/li\u003e\n\u003cli\u003eHeart Failure\u003c\/li\u003e\n\u003cli\u003eHeart Failure and Venous Thromboembolism – Samuel Z. Goldhaber, MD\u003c\/li\u003e\n\u003cli\u003eMore Than Just Diabetes and Heart Failure – SGLT2 – Deepak L. Bhatt, MD, MPH\u003c\/li\u003e\n\u003cli\u003eMore Than Just Diabetes and Heart Failure – GLP1 – Brendan M. Everett, MD, MPH\u003c\/li\u003e\n\u003cli\u003eHeart Failure – Reduced Ejection Fraction – Marc A. Pfeffer, MD, PhD\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – Akshay Suvas Desai, MD, MPH – Moderator\u003c\/li\u003e\n\u003cli\u003eHeart Failure – Preserved Ejection Fraction – Scott D. Solomon, PhD\u003c\/li\u003e\n\u003cli\u003eHeart Failure – Middle-of-the-Road Ejection Fraction – Navigating the Alphabet Soup – Michele A. Hamilton, MD\u003c\/li\u003e\n\u003cli\u003eCMR Imaging of Imaging of Heart Failure – Raymond Y. Kwong, MD, MPH\u003c\/li\u003e\n\u003cli\u003eAtrial Fibrillation \u0026amp; Coronary Disease\u003c\/li\u003e\n\u003cli\u003eDual Antiplatelet Therapy and Anticoagulation – Michelle L. O’Donoghue, MD, MPH\u003c\/li\u003e\n\u003cli\u003eHow to Manage the Anticoagulation Around Ablation and Cardioversions and Watchmans for AF – Bruce A. Koplan, MD\u003c\/li\u003e\n\u003cli\u003eAnticoagulation\u003c\/li\u003e\n\u003cli\u003eDose-Reduced Direct Oral Anticoagulants – Efficacy and Safety – Behnood Bikdeli, MD, MS\u003c\/li\u003e\n\u003cli\u003eDuration of Anticoagulation – Arterial Thrombosis – Navigating Limitations in Data and Variations in Practice – Teresa Carman, MD, RPVI, MSVM\u003c\/li\u003e\n\u003cli\u003eDuration of Anticoagulation – Venous Thrombosis – Gregory Piazza, MD, MS\u003c\/li\u003e\n\u003cli\u003eNovel Anticoagulation Targets – Factor XI and XII Inhibitors – Jeffrey I. Weitz, MD\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – Samuel Z. Goldhaber, MD – Moderator\u003c\/li\u003e\n\u003cli\u003eRacial Disparities In Arterial And Venous Thrombosis\u003c\/li\u003e\n\u003cli\u003eRacial Disparities in Healthcare – Cassandra M. Pierre, MD, MSc\u003c\/li\u003e\n\u003cli\u003eRacial Disparities in Arterial and Venous Thrombosis – Karlyn A. Martin, MD\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – Gregory Piazza, MD, MS – Moderator\u003c\/li\u003e\n\u003cli\u003eGenetics\u003c\/li\u003e\n\u003cli\u003eVTE Prediction – Using Genetics as a Powerful Tool – Nicholas A. Marston, MD, MPH\u003c\/li\u003e\n\u003cli\u003eClonal Hematopoiesis of Indeterminate Potential (CHIP) – Association with VTE \u0026amp; PAD – Peter Libby, MD\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – Gregory Piazza, MD, MS – Moderator\u003c\/li\u003e\n\u003cli\u003eCovid And Thrombosis\u003c\/li\u003e\n\u003cli\u003eCOVID and Thrombosis – Mechanisms and Epidemiology – Gregory Piazza, MD, MS\u003c\/li\u003e\n\u003cli\u003ePrevention of VTE in COVID-19 Patients – Behnood Bikdeli, MD, MS\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – Samuel Z. Goldhaber, MD – Moderator\u003c\/li\u003e\n\u003cli\u003eVTE Prevention\u003c\/li\u003e\n\u003cli\u003eVTE Prophylaxis for Orthopedic Surgery – Samuel Z. Goldhaber, MD\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – Ebrahim Barkoudah, MD, MPH – Moderator\u003c\/li\u003e\n\u003cli\u003ePE Reperfusion\u003c\/li\u003e\n\u003cli\u003eDevice Therapy for PE Reperfusion – Navigating a Rapidly Changing Landscape – Gregory Piazza, MD, MS\u003c\/li\u003e\n\u003cli\u003eSystemic Fibrinolysis (PEITHO-3) – Samuel Z. Goldhaber, MD\u003c\/li\u003e\n\u003cli\u003eAdventures with Hypertrophic Cardiomyopathy – 1958-2022 – Eugene Braunwald, MD\u003c\/li\u003e\n\u003cli\u003ePulmonary Hypertension and Thrombosis\u003c\/li\u003e\n\u003cli\u003eChronic Thromboembolic Pulmonary Hypertension – Bradley A. Maron, MD\u003c\/li\u003e\n\u003cli\u003ePulmonary Hypertension After PE That is Not Chronic Thromboembolic Pulmonary Hypertension – Jane A. Leopold, MD, FACC, FAHA, FSCAIc\u003c\/li\u003e\n\u003cli\u003ePost-Thrombotic Syndrome\u003cbr\u003ePost-thrombotic Syndrome – Epidemiology and Medical Therapy – Susan R. Kahn, MD, MSc, FRCPC, ABIM\u003c\/li\u003e\n\u003cli\u003eIntervention, Acute Intervention, and Chronic Venous Obstructive Disease – Suresh Vedantham, MD\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – Arvind K. Pandey, MD – Moderator\u003c\/li\u003e\n\u003cli\u003eVTE and Cancer\u003c\/li\u003e\n\u003cli\u003eVascular Cardio-Oncology – Javid Moslehi, MD\u003c\/li\u003e\n\u003cli\u003ePrevention of Thrombotic Complications of Cancer and Cancer Therapy – Simon Mantha, MD, MPH\u003c\/li\u003e\n\u003cli\u003eTreatment of Cancer-Associated Thrombosis – Michael B. Streiff, MD\u003c\/li\u003e\n\u003cli\u003eDiscussion\/Q\u0026amp;A – Jean Connors, MD – Moderator\u003c\/li\u003e\n\u003cli\u003eDate of Original Release: December 31, 2022\u003c\/li\u003e\n\u003cli\u003eDate Credits Expire: December 31, 2025\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954291085410,"sku":"MED-AMB00405","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Thrombosis-Thromboembolism-2022-CME-VIDEOS.jpg?v=1779370215","url":"https:\/\/meducourse.com\/products\/thrombosis-thromboembolism-2022","provider":"Meducourse","version":"1.0","type":"link"}